Maladies respiratoires et environnement : Publications / Awards

Accueil  >  Équipe 3  >  Publications selectionnées  >  Liste des publications

Liste des publications

Liste des Publications par ordre alphabétique du premier auteur

Les divers membres de l’équipe sont en gras

Aalioui L, Gouzi F, Tricot A (2022). “Reducing cognitive load during video lectures in physiology with eye movements modeling and pauses: a randomized controlled study.  “ . Adv Physiol Educ. 2022 Jun 1;46(2):288-296. (IF=2,29). Education, Scientific Disciplines (Q3) ; Physiology (Q3).

Alexandre F, Molinier V, Hayot M, Chevance G, Moullec G, Varray A, Héraud N. (2022). “Association between long-term oxygen therapy provided outside the guidelines and mortality in patients with COPD.BMJ Open. 2022 Jan 11;12(1):e049115. (IF=2,69). Medicine General and Internal (Q2).

Andreas S, Testa M, Boyer L, Brusselle G, Janssens W, Kerwin E, Papi A, Pek B, Puente-Maestu L, Saralaya D, Watz H, Wilkinson TMA, Casula D, Di Maro G, Lattanzi M, Moraschini L, Schoonbroodt S, Tasciotti A, Arora AK, Maltais F; NTHi-Mcat-002 study group avec comme collaborateur Bourdin A. (2022). “Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. “.Lancet Respir Med. 2022 May;10(5):435-446. (IF=30,70). Critical Care Medicine (Q1); Respiratory System  (Q1).

Bedin AS, Makinson A, Picot MC, Mennechet F, Malergue F, Pisoni A, Nyiramigisha E, Montagnier L, Bollore K, Debiesse S, Morquin D, Bourgoin P, Veyrenche N, Renault C, Foulongne V, Bret C, Bourdin A, Le Moing V, Van de Perre P, Tuaillon E. (2022). ”Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019. ” .J Infect Dis. 2022 Feb 15;225(4):744. . (IF=5,23). Immunology (Q2); Infectious Diseases (Q1).

Bertelli F, Suehs CM, Mallet JP, Court-Fortune I, Gagnadoux F, Borel JC, Gaubert O, Molinari N, Bourdin A, Jaffuel D . (2022). “Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea.  “ Respir Res. 2022 Mar 4;23(1):46. (IF=5,63). Respiratory Systems (Q1).

Bourdin A, Molinari N  (2022). ”Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma. ” .Respir Med. 2022 Jan;191:105999.  (IF=3,41). Cardiac and Cardiovascular Systems (Q2) ;  Respiratory System (Q2).

Brun JF , Varlet-Marie E, Myzia J, Raynaud de Mauverger E and Pretorius E  (2022). “Metabolic Influences Modulating Erythrocyte Deformability and Eryptosis.Metabolites 2022 12, 4. (IF=4,93). Biochemistry (Q2); Endocrinology, Diabetes and Metabolism (Q2); Molecular Biology (Q2).

Buhl R, Bel E, Bourdin A, IDávila I, Douglass JoA, FitzGerald JM, Jackson DJ, Lugogo P, Matucci A, Pavord ID, Wechsler ME, Kraft M. (2022). “Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion.JAIP 2022 Feb;10(2):422-432.. (IF=10,79). Allergy  (Q1) ;  Imunology (Q1).

Canonica GW, Bourdin A, Peters AT, Desrosiers M, Bachert C, Weidinger S, Simpson EL, Daizadeh N, Chen Z, Kamat S, Khan AH, Chao J, Graham NMH, Laws E, Rossi AB, Ardeleanu M, Mannent LP, Amin N, Ortiz B, Deniz Y, Djandji M, Rowe PJ (2022). “Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases.  “ . J Allergy Clin Immunol Pract. 2022 Mar 5:S2213-2198(22)00227-6.sous presse. (IF=10,79). Allergy  (Q1) ;  Imunology (Q1).

Carrère-Kremer S, Kolia-Diafouka P, Pisoni A, Bolloré K, Peries M, Godreuil S, Bourdin A, Van de Perre P, Tuaillon E.  (2022). “QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG. “  Front Microbiol. 2022 Apr 8;13:825021. (IF=5,64). Microbiology (Q1).

Charriot J, VolpatoM, Petit A, Vachier J, Bourdin A  (2022). “Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to “Unplug” from Our Daily Routine! .” Cells, 2022, 11(5), 812  (IF=6,60). Cell Biology (Q2).

Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Bergot E, Blanchard E, Borie R, Bourdin A, Chenivesse C, Clément A, Gomez E, Gondouin A, Hirschi S, Lebargy F, Marquette CH, Montani D, Prévot G, Quetant S, Reynaud-Gaubert M, Salaun M, Sanchez O, Trumbic B, Berkani K, Brillet PY, Campana M, Chalabreysse L, Chatté G, Debieuvre D, Ferretti G, Fourrier JM, Just N, Kambouchner M, Legrand B, Le Guillou F, Lhuillier JP, Mehdaoui A, Naccache JM, Paganon C, Rémy-Jardin M, Si-Mohamed S, Terrioux P; OrphaLung. (2022). “[French practical guidelines for the diagnosis and management of IPF – 2021 update, short version].  “Rev Mal Respir. 2022 Mar;39(3):275-312. (IF=0,62). Respiratory Systems (Q4).

Cottin V, Guéguen S, Nunes H, Jouneau S, Crestani B, Bonniaud P, Wemeau L, Israël-Biet D, Reynaud-Gaubert M, Gondouin A, Cadranel J, Marchand-Adam S, Chevereau M, Dufaure-Garé I, Amselem S, Clément A; and the RaDiCo team avec Bourdin A parmi les collaborateurs (2022). “Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort..Adv Ther. 2022 Jan;39(1):405-420. (IF=3,84). Medicine, Research and Experimental (Q2) ; Pharmacy and Pharmacology (Q1).

Eger K, Paroczai D, Bacon A, Schleich F, Sergejeva S, Bourdin A, Vachier I, Zervas E, Katsoulis K, Papapetrou D, Kostikas K, Csoma Z, Heffler E, Canonica GW, Grisle I, Bieksiene K, Palacionyte J, Ten Brinke A, Hashimoto S, Smeenk FWJM, Braunstahl GJ, van der Sar S, Mihălţan F, Nenasheva N, Peredelskaya M, Zvezdin B, Čekerevac I, Hromiš S, Ćupurdija V, Lazic Z, Milenkovic B, Dimic-Janjic S, Yasinska V, Dahlén B, Bossios A, Lazarinis N, Aronsson D, Egesten A, Munir AKM, Ahlbeck L, Janson C, Škrgat S, Edelbaher N, Leuppi J, Jaun F, Rüdiger J, Pavlov N, Gianella P, Fischer R, Charbonnier F, Chaudhuri R, Smith SJ, Doe S, Fawdon M, Masoli M, Heaney L, Haitchi HM, Kurukulaaratchy R, Fulton O, Frankemölle B, Gibson T, Needham K, Howarth P, Djukanovic R, Bel E, Hyland M (2022). “The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?  “ERJ Open Res 2022 May 16;8(2):00065-2022. (IF=2,60). Respiratory Systems (Q2).

El-Tahan MR, Erdoes G, van der Maaten J, Wilkinson K, Kousi T, Antoniou T, von Dossow V, Neto CN, Schindler E, Székely A, Forner AF, Wouters PF, Guarracino F, Burtin P, Unic-Stojanovic D, Schreiber JU, Matute P, Aboulfetouh F, Navarro-Ripoll R, Fassl J, Bettex D, Benedetto M, Szegedi L, Alston RP, Landoni G, Granell M, Gaudard P, Treskatsch S, Van Beersel D, Vuylsteke A, Howell S, Janai AR, Martinez AH, Erb JM, Vives M, El-Ashmawi H, Rex S, Mukherjee C, Paternoster G, Momeni M (2022). “European Association of Cardiothoracic Anesthesiology and Intensive Care Pediatric Cardiac Anesthesia Fellowship Curriculum: First Edition. “ .J Cardiothorac Vasc Anesth. 2022 Mar;36(3):645-653. (IF=2,63). Anesthesiology (Q3) ; CardiacCardiovascular Systems (Q3) ; Respiratory System (Q3) ; Peripheral Vascular Disease (Q3) .

Freycon-Tardy L, Ozdemir BA, Hireche K, Alric P, Canaud L. (2022). “Double Fenestrated Physician-Modified Stent Graft for Endovascular Treatment of Traumatic Aortic Isthmus Rupture With an Aberrant Right Subclavian Artery.J Endovasc Ther. 2022 Jan 29: sous presse. (IF=3,49). Surgery (Q2) ; Peripheral Vascular Diseases (Q2).

Grillet PE, Badiou S, Lambert K, Sutra T, Plawecki M, Raynaud de Mauverger E, Brun JF, Mercier J, Gouzi F, Cristol JP. (2022). “Biomarkers of Redox Balance Adjusted to Exercise Intensity as a Useful Tool to Identify Patients at Risk of Muscle Disease through Exercise Test.  “ Nutrients. 2022 Apr 29;14(9):1886. (IF=5,72). Nutrition and Dietetics  (Q1).

Hayot M, Saey D, Costes F, Bughin F, Chambellan A  (2022). “[Respiratory telerehabilitation in cases of COPD]. “ .Rev Mal Respir. 2022 Feb;39(2):140-151. (IF=0,62). Respiratory Systems (Q4).

Hireche K, Canaud L, Lounes Y, Aouinti S, Molinari N, Alric P. (2022). “Thoracoscopic Versus Open Lobectomy After Induction Therapy for Nonsmall Cell Lung Cancer: New Study Results and Meta-Analysis.  “ J Surg Res. 2022 Apr 21sous presse. (IF=2,19). Surgery (Q3).

Jaffuel D, Borel JC (2022). “If Oral Breathing Does Not Determine Mask Choice for CPAP Delivery, What Does?  “ . Am J Respir Crit Care Med. 2022 Apr 1.sous presse. (IF=21,40). Critical Care Medicine (Q1) ; Respiratory System (Q1).

Lanot N, Vincenti M, Abassi H, Bredy C, Agullo A, Gamon L, Mura T, Lavastre K, De La Villeon G, Barrea C, Meyer P, Rivier F, Meli AC, Fauconnier J, Cazorla O, Lacampagne A, Amedro P. (2022).Assessment of left ventricular dyssynchrony by speckle tracking echocardiography in children with duchenne muscular dystrophy.  “ Int J Cardiovasc Imaging. 2022 Jan;38(1):79-89. (IF=2,00). Cardiac and Cardiovascular Systems (Q3) ; Radiology, Nuclear Medicine and Medical Imaging (Q3) .

Laux X,  Rondet E, Grabulos J, Dore R, Ollier L, Virsolvy A, Mariano-goulart D, Maimoun L (2022) . ”  Ultrasonic transmission through small tubes such as rat tibias for axial Young’s modulus estimation: Discussion and recommendations  ” – Applied Acoustics, Volume 188, January 2022, 108573. (IF=2,64). Acoustics (Q2).

Levy B, Girerd N, Amour J, Besnier E, Nesseler N, Helms J, Delmas C, Sonneville R, Guidon C, Rozec B, David H, Bougon D, Chaouch O, Walid O, Hervé D, Belin N, Gaide-Chevronnay L, Rossignol P, Kimmoun A, Duarte K, Slutsky AS, Brodie D, Fellahi JL, Ouattara A, Combes A; HYPO-ECMO Trial Group and the International ECMO Network (ECMONet).avec parmi les collaborateurs Gaudard P (2022). “Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.JAMA. 2022 Feb 1;327(5):442-453. (IF=56,27). Medicine General and Internal (Q1).

Louis R, Satia I, Ojanguren I, Schleich F, Bonini M, Tonia T, Rigau D, Ten Brinke A, Buhl R, Loukides S, Kocks JWH, Boulet LP, Bourdin A, Coleman C, Needham K, Thomas M, Idzko M, Papi A, Porsbjerg C, Schuermans D, Soriano JB, Usmani OS. (2022).”European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults.  ” Eur Respir J. 2022 Feb 15:2101585. Sous presse. (IF=16,67). Respiratory Systems (Q1).

Luque-Paz D, Tattevin P, Loubet P, Bénézit F, Thibault V, Lainé F, Vanhems P, Amour S, Lina B, Duval X, L’Honneur AS, Fidouh N, Vallejo C, Alain S, Galtier F, Foulongne V, Lagathu G, Lenzi N, Lesieur Z, Launay O, Jouneau S; FLUVAC Study Group.(avec parmi les collaborateurs Bourdin, A , Klouche K ) Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study.  Sci Rep. 2022 Mar 10;12(1):4199. (IF= 4,38). Multidisciplinary Sciences  (Q1).

Mianné J, Nasri A, Van CN, Bourguignon C, Fieldès M, Ahmed E, Duthoit C, Martin N, Parrinello H, Louis A, Iché A, Gayon R, Samain F, Lamouroux L, Bouillé P, Bourdin A, Assou S, De Vos J  (2022). ”CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles. ” .BMC Biol. 2022 Jan 7;20(1):8.  (IF=7,43). Biology (Q1).

Naccache JN, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N,Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot E, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, DebrayMP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H, on behalf of the EXAFIP investigators and the OrphaLung network*(2022 “Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.“… The Lancet Respiratory Medicine Volume 10, Issue 1, January 2022, Pages 26-34. (IF=30,70) Critical Care Medicine (Q1); Respiratory System  (Q1).

Nesseler N, Fadel G, Mansour A, Para M, Falcoz PE, Mongardon N, Porto A, Bertier A, Levy B, Cadoz C, Guinot PG, Fouquet O, Fellahi JL, Ouattara A, Guihaire J, Ruggieri VG, Gaudard P, Labaste F, Clavier T, Brini K, Allou N, Lacroix C, Chommeloux J, Lebreton G, Matthay MA, Provenchere S, Flécher E, Vincentelli A; ECMOSARS Investigators. (2022). “Extracorporeal Membrane Oxygenation for Respiratory Failure Related to COVID-19: A Nationwide Cohort Study.  “ Anesthesiology. 2022 May 1;136(5):732-748. (IF=7,07). Anesthesiology (Q1).

Pavord ID, Bel EH, Bourdin A, Chan R, Han JK, Keene ON, Liu MC, Martin N, Papi A, Roufosse F, Steinfeld J, Wechsler ME, Yancey SW  (2022). “From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil driven diseases..Allergy. 2022 Mar;77(3):778-797. (IF=13,15). Allergy (Q1) ; Immunology (Q1).

Perrin A, Van Goethem C, Thèze C, Puechberty J, Guignard T, Lecardonnel B, Lacourt D, Métay C, Isapof A, Whalen S, Ferreiro A, Arne-Bes MC, Quijano-Roy S, Nectoux J, Leturcq F, Richard P, Larrieux M, Bergougnoux A, Pellestor F, Koenig M, Cossée M. (2022). “Long reads sequencing strategy to localize variants in TTN repeated domains.  “ J Mol Diagn. 2022 May 14:sous presse. (IF=5,57). Pathology (Q1).

Pitoulis FG, Nunez-Toldra R, Xiao K, Kit-Anan W, Mitzka S, Jabbour RJ, Harding SE, Perbellini F, Thum T, de Tombe PP, Terracciano CM  (2022). “Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro.”  . Cardiovasc Res. 2022 Feb 21;118(3):814-827. (IF=10,79). Cardiac and Cardiovascular Systems (Q1)

Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, Alacqua M, Al-Ahmad M, Al-Lehebi R, Altraja A, Belevskiy AS, Björnsdóttir US, Bourdin A, Busby J, Canonica GW, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Hansen S, Heaney LG, Heffler E, Hew M, Iwanaga T, Jackson DJ, Kocks JWH, Kallieri M, Bruce Ko HK, Koh MS, Larenas-Linnemann D, Lehtimäki LA, Loukides S, Lugogo N, Maspero J, Papaioannou AI, Perez-de-Llano L, Pitrez PM, Popov TA, Rasmussen LM, Rhee CK, Sadatsafavi M, Schmid J, Siddiqui S, Taillé C, Taube C, Torres-Duque CA, Ulrik C, Upham JW, Wang E, Wechsler ME, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, Hosseini N, Rowlands MA, Price D, van Boven JF.(2022). “Global Vty in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.J Allergy Clin Immunol Pract.2022 May;10(5):1202-1216.e23. (IF=10,79). Allergy  (Q1) ;  Imunology (Q1).

Reisqs JB, Moreau A, Charrabi A, Sleiman Y, Meli AC, Millat G, Briand V, Beauverger P, Richard S, Chevalier P (2022). “ The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy.  . Clin Transl Med. 2022 Mar;12(3):e748. (IF=11,49). Oncology (Q1); Medicine, Research and Experimental (Q1).

Rouhana S, Virsolvy A, Fares N, Richard S, Thireau J- (2022). “ Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning  Pharmaceuticals, 2022, 15, 31. Sous presse (IF=5,86). Pharmacology and Pharmacy  (Q1) ; Chemistry, Medicinal (Q1).

Seisel Q, Lakumpa I, Josse E, Vivès E, Varilh J, Taulan-Cadars M, Boisguérin P. (2022).Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide.  ” Pharmaceutics. 2022 Apr 7;14(4):808. (IF=6,32). Pharmacology and Pharmacy  (Q1)

Tamisier R, Damy T, Bailly S, Davy JM, Verbraecken J, Lavergne F, Palot A, Goutorbe F, d’Ortho MP, Pépin JL; FACE study investigators, avec parmi les collaborateurs, Mallet JP (2022). “Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data.  “ Thorax, 2022 Feb;77(2):178-185. (IF=9,14). Respiratory System (Q1).

Vernisse C, Petit A, Pantesco V, Chanez P, Gras D, Tuaillon E, Duperray C, Vachier I,Assou S,  Bourdin A. (2022) “Using intracellular SCGB1A1-sorted, formalin-fixed club cells for successful transcriptomic analysis“  BBRC  2022 May 14;604:151-157.. (IF=3,57). Biochemistry and Molecular Biology (Q3); Biophysics (Q2).

Warren CM, Halas M, Goldspink PH, Feng HZ, Herren AW, Wolska BM, de Tombe PP, Jin JP, Solaro RJ.  (2022). “Truncation of the N-terminus of cardiac troponin I initiates adaptive remodeling of the myocardial proteosome via phosphorylation of mechano-sensitive signaling pathways.  “ Mol Cell Biochem. 2022 Jun;477(6):1803-1815.. (IF=3,40). Cell Biomlogy (Q3).

Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M. (2022. “Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.  “. Lancet Respir Med. 2022 Jan;10(1):11-25. (IF=30,70). Critical Care Medicine (Q1); Respiratory System  (Q1).

Ahmed E, Vachier I, Charriot J, Bourdin A. (2021). “Identifier et prendre en charge l’asthme difficileLa Presse Médicale Formation, Volume 2, Issue 2, May 2021, Pages 159-165. (IF=  ) Medicine General and Internal (Qx).

Ahmed E, Fieldes M, Mianné J, Bourguignon C, Nasri A, Vachier I, Assou S, Bourdin A, De Vos J  (2021). “Generation of four severe early-onset chronic obstructive pulmonary disease (COPD) patient-derived induced pluripotent stem cell lines from peripheral blood mononuclear cells.Stem Cell Res. 2021 Oct;56:102550.  (IF=2,02). Biotecnology and Applied Microbiology (Q4) ; Cell and Time engenneering (Q4) ; Cell Biology (Q4).

Alonso W, Ozdemir BA, Chassin-Trubert L, Ziza V, Alric P, Canaud L  (2021). “Early outcomes of native and graft related abdominal aortic infection managed with orthotopic xenopericardial grafts.  “ J Vasc Surg. 2021 Jan;73(1):222-231. (IF=4,27) Peripheral Vascular Disease (Q2).

Amalric M, Ahmed E, Jung B, Suehs C, Molinari N, Bourdin A, Charriot J.  (2021). “Association between increased mortality and bronchial fibroscopy in intensive care units and intermediate care units during COPD exacerbations: an analysis of the 2014 and 2015 National French Medical-based Information System Databases (PMSI). “  J Intensive Care. 2021 Jun 15;9(1):45. (IF=3,95). Critical Care and Intensive Care Medicine (Q1).

Bargnoux AS, Kuster N, Sutra T, Laroche L, Rodriguez A, Morena M, Chenine L, Chalabi L, Dupuy AM, Badiou S, Cristol JP.  (2021). “Evaluation of a new point-of-care testing for creatinine and urea measurement.  “ Scand J Clin Lab Invest. 2021 Jul;81(4):290-297. (IF=1,71). Medicine, Resaerch and Experimental (Q4).

Barry P, Mall M, Alvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group..(Parmi les collaborateurs Bourdin A) (2021). “.Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes. “. N Engl J Med. 2021 Aug 26;385(9):815-825.  (IF=91,24). Medicine, General and Internal (Q1).

Baudry G, Nesseler N, Flecher E, Vincentelli A, Goeminne C, Delmas C, Porterie J, Nubret K, Pernot M, Kindo M, Hoang Minh T, Rouvière P, Gaudard P, Michel M, Senage T, Boignard A, Chavanon O, Para M, Verdonk C, Pelcé E, Gariboldi V, Anselme F, Litzler PY, Blanchart K, Babatasi G, Bielefeld M, Bouchot O, Hamon D, Lellouche N, Bailleul X, Genet T, Eschalier R, d’Ostrevy N, Bories MC, Akar RA, Blangy H, Vanhuyse F, Obadia JF, Galand V, Pozzi M.  “Characteristics and outcome of ambulatory heart failure patients receiving a left ventricular assist device.  “ ESC Heart Fail. 2021 Dec;8(6):5159-5167 (IF=4,41). Cardiac and Cardiovascular Systems  (Q1).

Baux D, Van Goethem C, Ardouin O, Guignard T, Bergougnoux A, Koenig M, Roux AF (2021). “MobiDetails: online DNA variants interpretation. “  Eur J Hum Genet. 2021 Feb;29(2):356-360. (IF=4,25). Biochemistry and Molecular Biology (Q2); Genetics and Heredity (Q2).

Bedin AS, Makinson A, Picot MC, Mennechet F, Malergue F, Pisoni A, Nyiramigisha E, Montagnier L, Bollore K, Debiesse S, Morquin D, Bourgoin P, Veyrenche N, Renault C, Foulongne V, Bret C, Bourdin A, Le Moing V, Van de Perre P, Tuaillon E (2021). Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19.  . J Infect Dis. 2021 Feb 24;223(4):562-567. (IF=5,23). Infectious Diseases (Q2) ; Microbiology (Q1).

Bergougnoux A, Ea V, Paris F, Kalfa N  (2021). ” Reply to Zhongzhong Chen, Hua Xie, and Fang Chen’s Letter to the Editor re: Vuthy Ea, Anne Bergougnoux, Pascal Philibert, et al. How Far Should We Explore Hypospadias? Next-generation Sequencing Applied to a Large Cohort of Hypospadiac Patients. Eur Urol 2021;79:507-15.  ” Eur Urol. 2021 Jul;80(1):e12-e13. (IF=20,10). Urology and Nephrology (Q1).

Bertelli F, Suehs CM, Mallet JP, Rotty MC, Pepin JL, Gagnadoux F, Matzner-Lober E, Bourdin A, Molinari N, Jaffuel D.  (2021). “Apnoea-hypopnoea indices determined via continuous positive airway pressure (AHI-CPAPflow) versus those determined by polysomnography (AHI-PSGgold): a protocol for a systematic review and meta-analysis.  “ BMJ Open. 2021 May 10;11(5):e044499. (IF=2,69). Medicine (Q1).

Blervaque L, Préfaut C, Forthin H, Maffre F, Bourrelier M, Héraud N, Catteau M, Pomiès P, Jaffuel D, Molinari N, Hayot M, Gouzi F. Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study.  Respir Res. 2021 Mar 10;22(1):79.(IF=5,63). Respiratory Systems (Q2).

Bommart S, Charriot J, Nagot N, Vernhet-Kovacsik H, Revel MP, Boissin C, Bourdin A, Tuaillon E  (2021). “Differentiating between active and latent tuberculosis with chest computed tomography.  “ Diagn Interv Imaging. 2021 Oct;102(10):605-610. (IF=4,03). Radiology, Nuclear Medicine and Medical imaging  (Q2).

Bommart S, Pujol JL, Coffy A, Daurès JP, Roch B. (2021). “Authors reply to letter to the editor by Dr Degens et al.  Lung Cancer. 2021 Mar;153:185.. (IF=5,70). Oncology (Q2) ; Respiratory System (Q1).

Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S.  (2021). “Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies.  “ Front Cardiovasc Med. 2021 Jun 30;8:690533.  (IF=6,05). Cardiac and Cardiovascular Systems (Q2).

Boucly A, Weatherald J, Savale L, de Groote P, Cottin V, Prévot G, Chaouat A, Picard F, Horeau-Langlard D, Bourdin A, Jutant EM, Beurnier A, Jevnikar M, Jaïs X, Simonneau G, Montani D, Sitbon O, Humbert M (2021). “External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry. “ .Eur Respir J. 2021 Nov 4:2102419. (IF=16,67). Respiratory Systems (Q1).

Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O (2021). “Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension. “.Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. (IF=21,40). Critical Care Medicine (Q1) ; Respiratory System (Q1)).

Bourdin ACharriot J, Boissin C, Ahmed E, Suehs C, De Sevin A, Volpato M, Pahus L, Gras D, Vachier I, Halimi L, Hamerlijnck D, Chanez P. (2021). “Will the asthma revolution fostered by biologics also benefit adult ICU patients?Allergy. 2021 Aug;76(8):2395-2406.  (IF=13,15). Allergy (Q1) ; Immunology (Q1).

Bourdin A, Molinari N, Ferguson GT, Singh B, Siddiqui MK, Holmgren U, Ouwens M, Jenkins M, De Nigris E  (2021). ” Efficacy and Safety of Budesonide/Glycopyrronium / Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.  ”. Adv Ther. 2021 Jun;38(6):3089-3112. (IF=3,84). Medicine, Research and Experimental (Q2) ; Pharmacy and Pharmacology (Q1).

Bourdin A, Papi AA, Corren J, Virchow JC, Rice MS, Deniz Y, Djandji M, Rowe P, Pavord ID. (2021). “Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline.  “ Allergy. 2021 Jan;76(1):269-280. (IF=13,15). Immunology (Q1).

Bourdin A, Criner G, Devouassoux G, Dransfield M, Halpin DMG, Han MK, Jones CE, Kalhan R, Lange P, Lettis S, Lipson DA, Lomas DA, Echave-Sustaeta María-Tomé JM, Martin N, Martinez FJ, Quasny H, Sail L, Siler TM, Singh D, Thomashow B, Watz H, Wise R, Hanania NA.  (2021). ” InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. .  ” Chronic Obstr Pulm Dis. 2021 Jan;8(1). (IF=3,39). Respiratory System (Q3).

Bousquet J, Czarlewski W, Zuberbier T, Mullol J, Blain H, Cristol JP, De La Torre R, Pizarro Lozano N, Le Moing V, Bedbrook A, Agache I, Akdis CA, Canonica GW, Cruz AA, Fiocchi A, Fonseca JA, Fonseca S, Gemicioğlu B, Haahtela T, Iaccarino G, Ivancevich JC, Jutel M, Klimek L, Kraxner H, Kuna P, Larenas-Linnemann DE, Martineau A, Melén E, Okamoto Y, Papadopoulos NG, Pfaar O, Regateiro FS, Reynes J, Rolland Y, Rouadi PW, Samolinski B, Sheikh A, Toppila-Salmi S, Valiulis A, Choi HJ, Kim HJ, Anto JM (2021). “Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19.  “  Int Arch Allergy Immunol. 2021 Feb 10:1-15. (IF=2,75). Allergy (Q3) ; Immunology (Q3).

Bughin F, Bui G, Ayoub B, Blervaque L, Saey D, Avignon A, Brun JF, Molinari N, Pomies P, Mercier J, Gouzi F, Hayot M  (2021).”Impact of a Mobile Telerehabilitation Solution on Metabolic Health Outcomes and Rehabilitation Adherence in Patients With Obesity: Randomized Controlled Trial. ” .JMIR Mhealth Uhealth. 2021 Dec 6;9(12):e28242.(IF=4,77). Health Care Sciences and Services (Q1) ; Medical Informatics (Q2).

Buhl R, Bel E, Bourdin A, IDávila I, Douglass JoA, FitzGerald JM, Jackson DJ, Lugogo P, Matucci A, Pavord ID, Wechsler ME, Kraft M. (2021). “Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion.JAIP, 2021sous presse. (IF=10,79). Allergy  (Q1) ;  Imunology (Q1).

Burgarelli Lages E, Salgado Fernandes R, Sena Andrade M, Paiyabhroma N, Barbosa de Oliveira R, FernandesC, Dantas Cassali G, Sicard P, Richard S, Branco de Barros AL, Miranda Ferreira LA. (2021) “pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects. “  Biomedicine & Pharmacotherapy, 2021 Dec;144:112373. (IF=6,53). Pharmacology and pharmacy (Q1).

Cazorla O, Barthélémy I, Su JB, Meli AC, Chetboul V, Scheuermann V, Gouni V, Anglerot C, Richard S, Blot S, Ghaleh B, Lacampagne A (2021). “Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy. “ J Am Coll Cardiol. 2021 Dec 14;78(24):2439-2453. (IF=24,01). Cardiac ad Ca rdiovascular Systems  (Q1).

De Brandt J, Burtin C, Pomiès P, Vandenabeele F, Verboven K, Aumann J, Blancquaert L, Everaert I, Van Ryckeghem L, Cops J, Hayot M, Spruit MA, Derave W  (2021). “Carnosine, oxidative and carbonyl stress, antioxidants and muscle fiber characteristics of quadriceps muscle of patients with COPD.  “. J Appl Physiol (1985). 2021 Jul 29. Sous presse. (IF=3,53). Physiology (Q2) ; Sport Sciences (Q1).

Catteau M, Passerieux E, Blervaque L, Gouzi F, Hayot M, Pomies P (2021).“ Response to Electrostimulation Is Impaired in Muscle Cells from Patients with Chronic Obstructive Pulmonary Disease.– Cells, 2021 sous presse. (IF=6,60) Cell Biology  (Q2).

Certain MC, Chaumais MC, Jaïs X, Savale L, Seferian A, Parent F, Georges M, Favrolt N, Bourdin A, Boissin C, Cottin V, Traclet J, Renard S, Noel V, Picard F, Girerd B, Marie-Rosa G, Perros F, Sitbon O, Bonniaud P, Humbert M, Montani D.  (2021). “Characteristics and long-term outcomes of pulmonary veno-occlusive disease induced by Mitomycin-C.  “ Chest. 2021 Mar;159(3):1197-1207 (IF=9,41). Respiratory System (Q1).

Chapel B, Alexandre F,Heraud N, Ologeanu-Taddei R,Cases AS, Bughin F;  Hayot M. (2021). “Telerehabilitation assessment domains and process in chronic diseases: a scoping meta-review“. “. BMC Health Service Res 2021 sous resse (IF=2,65). Health Care Sciences and Services (Q3).

Charriot J, Maravic M, Huguet M, Vachier I, Suehs C, Bourdin A… –  (2021).“Real-life” management of patients with severe asthma in the biologics era: Can we do better?World Allergy Organization 2021 Mar 18;14(4):100528 (IF=4,08). Allergy (Q3); Immunology (Q2)

Chen E, Nesseler N, Martins RP, Goéminne C, Vincentelli A, Delmas C, Porterie J, Nubret K, Pernot M, Kindo M, Minh TH, Gaudard P, Rouvière P, Michel M, Sénage T, Boignard A, Chavanon O, Verdonk C, Para M, Pelcé E, Gariboldi V, Pozzi M, Baudry G, Litzler PY, Anselme F, Blanchart K, Babatasi G, Garnier F, Bielefeld M, Radu C, Lellouche N, Bourguignon T, Genet T, Eschalier R, D’Ostrevy N, Bories MC, Baudinaud P, Vanhuyse F, Blangy H, Leclercq C, Flécher E, Galand V.  (2021). “Comparison of Outcomes and Mortality in Patients Having Left Ventricular Assist Device Implanted Early -vs- Late After Diagnosis of Cardiomyopathy.  “ Am J Cardiol. 2021 May 1;146:82-88. (IF=2,78). Cardiac and Cardiovascular Systems (Q2).

Chung C, Bommart S, Marchand-Adam S, Lederlin M, Fournel L, Charpentier MC, Groussin L, Wislez M, Revel MP, Chassagnon G. (2021). “Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience.  “ J Clin Med. 2021 Jun 30;10(13):2950. (IF=4,24). Medicine, General and Internal (Q1).

Collier JJ, Guissart C, Oláhová M, Sasorith S, Piron-Prunier F, Suomi F, Zhang D, Martinez-Lopez N, Leboucq N, Bahr A, Azzarello-Burri S, Reich S, Schöls L, Polvikoski TM, Meyer P, Larrieu L, Schaefer AM, Alsaif HS, Alyamani S, Zuchner S, Barbosa IA, Deshpande C, Pyle A, Rauch A, Synofzik M, Alkuraya FS, Rivier F, Ryten M, McFarland R, Delahodde A, McWilliams TG, Koenig M, Taylor RW. (2021). “Developmental Consequences of Defective ATG7-Mediated Autophagy in Humans. “  N Engl J Med. 2021 Jun 24;384(25):2406-2417. (IF=91,24). Medicine, General and Internal (Q1).

David H, Ughetto A, Gaudard P, Plawecki M, Paiyabhroma N, Zub E, Colson P, Richard S, Marchi N, Sicard P. (2021). “Experimental Myocardial Infarction Elicits Time-Dependent Patterns of Vascular Hypoxia in Peripheral Organs and in the Brain. “ Front Cardiovasc Med. 2021 Jan 27;7:615507. (IF=6,05). Cardiac and Cardiovascular Systems (Q2).

De Brandt J, Burtin C, Pomiès P, Vandenabeele F, Verboven K, Aumann J, Blancquaert L, Everaert I, Van Ryckeghem L, Cops J, Hayot M, Spruit MA, Derave W  (2021). “Carnosine, oxidative and carbonyl stress, antioxidants and muscle fiber characteristics of quadriceps muscle of patients with COPD.  “. J Appl Physiol (1985). 2021 Oct 1;131(4):1230-1240.(IF=3,53). Physiology (Q2) ; Sport Sciences (Q1).

Fieldes M, Bourguignon C, Assou S, Nasri A, Fort A, Vachier I, De Vos J, Ahmed E, Bourdin A. (2021). “Targeted therapy in eosinophilic chronic obstructive pulmonary disease.  “ ERJ Open Res. 2021 Apr 12;7(2):00437-2020. (IF=2,60). Pulmonary and Respiratory Medicine (Q1).

Garcia GM, Roy J, Pitta V, Abdalla DSP, Grabe-Guimarães Andrea, Mosqueira VCF,  and Richard S (2021). “Polylactide Nanocapsules Attenuate Adverse Cardiac Cellular Effects of Lyso-7, a Pan-PPAR Agonist/Anti-Inflammatory New Thiazolidinedione“- Pharmaceutics, 2021 sous presse (IF=6,32). Pharmacology and Pharmacy  (Q1)

Garcon C, Abdelnour H, Jeandel C, Louahem D, Laffont I, Cottalorda J, Lambert K, Coulet B, Delpont M. (2021). “Change in shoulder external rotation strength and motion after lower trapezius transfer to the infraspinatus in children with obstetric brachial plexus palsy.Int Orthop. 2021 Oct 18. Sous presse. (IF=3,07). Orthopedics (Q2).

Godet C, Couturaud F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Bourdin A, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, Rivière F, Garcia G, Caillaud D, Blanc FX, Goupil F, Bergeron A, Gondouin A, Frat JP, Flament T, Camara B, Priou P, Brun AL, Laurent F, Ragot S, Cadranel J; NebuLamB* study group and GREPI network (2021). “Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multicentre, trial. “ .Eur Respir J. 2021 Nov 11:  sous presse; (IF=16,67). Respiratory Systems (Q1).

Goulabchand R, Roubille C, Montani D, Fesler P, Bourdin A, Malafaye N, Morel J, Arnaud E, Lattuca B, Barateau L, Guilpain P, Mura T  (2021); “Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database. “.J Clin Med. 2021 Oct 30;10(21):5115.

Gouzi F, Ayache D, Hedon C, Molinari N, Vicet A (2021). .Breath acetone concentration: too heterogeneous to constitute a diagnosis or prognosis biomarker in heart failure? A systematic review and meta-analysis. J Breath Res. 2021 Nov 16;16(1).. (IF=3,26). Biochemical Research Methods (Q1); Respiratory Systems (Q1).

Grillet PE, Le Souder C, Rohou J, Cazorla O, Charriot J, Bourdin A.  (2021).“Glycopyrrolate and formoterol fumarate for the treatment of COPD. “ Expert Rev Respir Med. 2021 Jan;15(1):13-25. (IF= 3,77). Respiratory System (Q2).

Guarracino F, Habicher M, Treskatsch S, Sander M, Szekely A, Paternoster G, Salvi L, Lysenko L, Gaudard P, Giannakopoulos P, Kilger E, Rompola A, Häberle H, Knotzer J, Schirmer U, Fellahi JL, Hajjar LA, Kettner S, Groesdonk HV, Heringlake M (2021). “ Vasopressor Therapy in Cardiac Surgery-An Experts’ Consensus Statement.  “  J Cardiothorac Vasc Anesth. 2021 Apr;35(4):1018-1029.. (IF= 2,63). Anesthesiology (Q3) ; Cardiac Cardiovascular Systems (Q3) ;  Respiratory System (Q3) ; Peripheral Vascular Disease (Q3) .

Halimi L, Suehs CM, Marin G, Boissin C, Gamez AS, Vachier I, Molinari N, Bourdin A. (2021). “Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study.ERJ Open Res. 2021 Aug 23;7(3):00617-2020. (IF=2,60). Respiratory System (Q2).

Hatton A, Bergougnoux A, Zybert K, Chevalier B, Mesbahi M, Altéri JP, Walicka-Serzysko K, Postek M, Taulan-Cadars M, Edelman A, Hinzpeter A, Claustres M, Girodon E, Raynal C, Sermet-Gaudelus I, Sands D (2021). “Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forward. “ .J Cyst Fibros. 2021 Dec 20:S1569-1993(21)02169-X. (IF=5,48). Respiratory Systems (Q1).

Heaney LG, Perez de Llano L, Al-Ahmad M, Backer V, Busby J, Canonica GW, Christoff GC, Cosio BG, FitzGerald JM, Heffler E, Iwanaga T, Jackson DJ, Menzies-Gow AN, Papadopoulos NG, Papaioannou AI, Pfeffer PE, Popov TA, Porsbjerg CM, Rhee CK, Sadatsafavi M, Tohda Y, Wang E, Wechsler ME, Alacqua M, Altraja A, Bjermer L, Björnsdóttir US, Bourdin A, Brusselle GG, Buhl R, Costello RW, Hew M, Siyue MK, Lehmann S, Lehtimäki L, Peters M, Taillé C, Taube C, Tran TN, Zangrilli J, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Hosseini N, Kerkhof M, Murray RB, Price CA, Price DB (2021). “Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort.  “  Chest. 2021 Sep;160(3):814-830 (IF=9,41). Critical Care Medicine ( Q1) ; Respiratory System (Q1).

Hedon C, Lambert K, Chakouri N, Thireau J, Aimond F, Cassan C, Bideaux P, Richard S, Faucherre A, Le Guennec JY, Demion M.  (2020). .”New role of TRPM4 channel in the cardiac excitation-contraction coupling in response to physiological and pathological hypertrophy in mouse.  .” Prog Biophys Mol Biol.. 2021 Jan;159:105-117. (IF=3,67). Biochemistry and Molecular Biology (Q3) ;  Biophysics (Q3).

Hghland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM; SENSCIS trial investigators. (2021). “Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial”.  Lancet Respir Med. 2021 Jan;9(1):96-106. (IF=30,70). Critical Care Medicine (Q1); Respiratory System (Q1).

Homan T, Delanoë-Ayari H, Meli AC, Cazorla O, Gergely C, Mejat A, Chevalier P, Moreau A.(2021). “MorphoScript: a dedicated analysis to assess the morphology and contractile structures of cardiomyocytes derived from stem cells.  “ Bioinformatics. 2021 May 28:btab400. (IF=6,94). Biochemical Research Methods (Q1); Biotechnology and Applied Microbiology (Q1); Mathematical and Computational Biology (Q1; Computer Science and Interdisciplinary applications (Q1); Statistics and Probability (Q1).

Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB; PULSAR Trial Investigators. (Parmi les collaborateurs Bourdin A).  (2021). “Sotatercept for the Treatment of Pulmonary Arterial Hypertension.  “ N Engl J Med. 2021 Apr 1;384(13):1204-1215. (IF=91,24). Medicine, General and Internal (Q1).

Jaffuel D, Nogue E, Berdague P, Galinier M, Fournier P, Dupuis M, Georger F, Cadars MP, Ricci JE, Plouvier N, Picard F, Puel V, Mallet JP, Suehs CM, Molinari N, Bourdin A, Roubille F (2021). “Sacubitril-valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO-SAS study.  “ ESC Heart Fail. 2021 Aug;8(4):2513-2526. . (IF=4,41). Cardiac and Cardiovascular Systems  (Q1).

Jaffuel D, Fabry-Vendrand C, Darnal E, Wilczynski O, Pain E, Bourdin A  (2021). “Perception of oral corticosteroids in adult patients with asthma in France.  “. J Asthma. 2021 Jul;58(7):946-957 (IF=2,51). Respirtory Sytem (Q3);  Allergy (Q3).

Jelinkova S, Sleiman Y, Fojtík P, Aimond F, Finan A, Hugon G, Scheuermann V, Beckerová D, Cazorla O, Vincenti M, Amedro P, Richard S, Jaros J, Dvorak P, Lacampagne A, Carnac G, Rotrekl V, Meli AC. (2021). “Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.  Int J Mol Sci. 2021 May 10;22(9):5025.(IF=5,92). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary  (Q2).

Kalmanovich E, Battistella P, Rouviere P, Albat B, Frapier JM, Demaria R, Huet F, Agullo A, Mourad M, Colson P, Leclercq F, Gaudard P and Roubille F.(2021).  Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients Future Science OA, (2021) FSO689 (IF=2,18). Biotechnology (Q3); Medicine (miscellaneous) (Q3).

Korn S, Bourdin A, Chupp G, Cosio BG, Arbetter D, Shah M, Gil EG . (2021). “Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to Five Years.  “  J Allergy Clin Immunol Pract. 2021 Dec;9(12):4381-4392.e4. (IF=10,79). Allergy  (Q1) ; Imunology (Q1).

Lambert K, Demion M, Lagacé JC, Hokayem M, Dass M, Virsolvy A, Jover B, Bourret A, Bisbal C. (2021) Grape polyphenols and exercise training have distinct molecular effects on cardiac hypertrophy in a model of obese insulin-resistant rats.  J Nutr Biochem. 2021 Jan;87:108522 (IF=6,05). Biochemistry and Molecular Biology (Q1) ; Nutrition and dietetics (Q1).

Lange P, Ahmed E, Lahmar ZM, Martinez FJ, Bourdin A  (2021). «Natural history and mechanisms of COPD.   Respirology. 2021 Apr;26(4):298-321.. (IF=6,24). Respiratory System (Q1).

Lertwanakarn T, Suntravat M, Sánchez EE, Wolska BM, Solaro RJ, de Tombe PP, Tachampa K. (2021). ”Negative inotropic mechanisms of β-cardiotoxin in cardiomyocytes by depression of myofilament ATPase activity without activation of the classical β-adrenergic pathway.Sci Rep. 2021 Oct 27;11(1):21154. (IF=4,38). Multidisciplinary Sciences  (Q1).

Lotierzo M, Bruno R, Finan-Marchi A, Huet F, Kalmanovich E, Rodrigues G, Dupuy AM, Adda J, Piquemal D, Richard S, Cristol JP, Roubille F (2021). “ Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure? “ .Medicina (Kaunas). 2021 Sep 22;57(10):996. . (IF=1,20=. Generzl Medicine (Q2).

Lounes Y, Chassin-Trubert L, Gandet T, Ozdemir BA, Peyron A, Akodad M, Alric P, Canaud L (2021). “ Endovascular aortic arch repair with a pre-cannulated double-fenestrated physician-modified stent graft: a benchtop experiment.  “. Interact Cardiovasc Thorac Surg. 2021 May 27;32(6):942-949. Et Interact Cardiovasc Thorac Surg. 2021 Jul 19:ivab196. (IF=1,90). Cardiac and Cardiovascular Systems (Q3); Respiratory System (Q4); Surgery (Q3).

Lynch TL 4th, Kumar M, McNamara JW, Kuster DWD, Sivaguru M, Singh RR, Previs MJ, Lee KH, Kuffel G, Zilliox MJ, Lin BL, Ma W, Gibson AM, Blaxall BC, Nieman ML, Lorenz JN, Leichter DM, Leary OP, Janssen PML, de Tombe PP, Gilbert RJ, Craig R, Irving T, Warshaw DM, Sadayappan S (2021). “Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility. “   J Mol Cell Cardiol. 2021 Mar 26;156:33-44. (IF=5,00). Cardiac and Cardiovascular Systems (Q1) ; Domaine de Recherche Cell Biology (Q2).

Martin N, Bergougnoux A, Baatallah N, Chevalier B, Varilh J, Baux D, Costes B, Fanen P, Raynal C, Sermet-Gaudelus I, Girodon E, Taulan-Cadars M, Hinzpeter A  (2021). “Exon identity influences splicing induced by exonic variants and in silico prediction efficacy.J Cyst Fibros. 2021 May;20(3):464-472. (IF=5,48). Respiratory Systems (Q1).

Mattei L, Suehs CM, Alagha K, Bourdin A, Brousse C, Charriot J, Devouassoux G, Fry S, Guilleminault L, Gouitaa M, Taille C, Chanez P, Pahus L. (2021). “Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study.Ther Adv Respir Dis. 2021 Jan-Dec 2021;15:17534666211049735. (IF=4,03). Respiratory System (Q2).

Melhem N, Chajadine M, Gomez I, Howangyin KY, Bouvet M, Knosp C, Sun Y, Rouanet M, Laurans L, Cazorla O, Lemitre M, Vilar J, Mallat Z, Tedgui A, Ait-Oufella H, Hulot JS, Callebert J, Launay JM, Fauconnier J, Silvestre JS, and Taleb S. (2020) “ Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine.  “Circulation, 2021 Feb 9;143(6):566-580. (IF= 29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).

Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, Brightling CE, Griffiths JM, Hellqvist Å, Bowen K, Kaur P, Almqvist G, Ponnarambil S, Colice G  (2021). “Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.  “ N Engl J Med. 2021 May 13;384(19):1800-1809.(IF=91,24). Medicine, General and Internal (Q1).

Moreau A, Reisqs JB, Delanoe-Ayari H, Pierre M, Janin A, Deliniere A, Bessière F, Meli AC, Charrabi A, Lafont E, Valla C, Bauer D, Morel E, Gache V, Millat G, Nissan X, Faucherre A, Jopling C, Richard S, Mejat A, Chevalier P. (2021). “Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy.  “ Clin Transl Med. 2021 Mar;11(3):e319. (IF=11,49). Oncology (Q1); Medicine, Research and Experimental (Q1).

Nasri A, Foisset F, Ahmed E, Lahmar Z, Vachier I, Jorgensen C,  Assou S, Bourdin A and De Vos J. (2021). “  Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary DiseaseCells, 2021 Dec 9;10(12):3467 (IF=  6,60). Cell Biology  (Q2).

Nassar R, Vernus B, Carnac G, Fouret G,Goustard B, Casas F, Tintignac L, ICassar-Malek I, Picard B, ISeiliez I, Brioche T,Koechlin-Ramonatxo C, Bertrand-Gaday C, Hamade A, Najjar F, Chabi B, Bonnieu A. (2021). “  Myostatin gene inactivation increases post-mortem calpain-dependent muscle proteolysis in mice.Meat Science 2021 sous presse. (IF=5,21). Food Science and Technology (Q1).

Nassib J, Hireche K, Ozdemir BA, Alric P, Canaud L (2021). “Fate of the Dissected Thoraco-Abdominal Aorta Distal to TEVAR (Thoracic Endovascular Aortic Repair) for Complicated Acute and Subacute Type B Aortic Dissection.J Endovasc Ther. 2021 Dec 27: sous presse. (IF=3,49). Surgery (Q2) ; Peripheral Vascular Diseases (Q2).

Pineau F, Caimmi D, Taviaux S, Reveil M, Brosseau L, Rivals I, Drevait M, Vachier I, Claustres M, Chiron R, De Sario A (2021). “DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study. “  Genes (Basel). 2021 Mar 19;12(3):441. (IF=4,10). Genetics and Heradity (Q2)

Porsbjerg C, Maitland-van der Zee AH, Brusselle G, Canonica GW, Agusti A, Faner R, Vogelmeier CF, Nawijn M, van den Berge M, Rusconi F, Pilette C, Ramiconi V, Coleman C, Chaudhuri R, Chung KF, Wedzicha J, Saglani S, Van der Schee MP, Heaney L, Bourdin A, Roberts G, Djukanovic R, Kuna P, Kupczyk M, Axmann J, Staudinger H, Clarke GW, Dahlen SE, Brightling C (2021). “3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD. “ .Eur Respir J. 2021 Oct 21;58(4):2102168. (IF=16,67). Respiratory Systems (Q1).

Pujol JL, Thomas PA, Giraud P, Denis MG, Tretarre B, Roch B, Bommart S.  (2021). “Lung Cancer in France.  “ J Thorac Oncol. 2021 Jan;16(1):21-29. (IF=15,61). Oncology (Q1); Respiratory System ((Q1).

Pujol JL, Thomas PA, Giraud P, Denis MG, Tretarre B, Roch B, Bommart S. (2021). “Lung Cancer in France.  “ J Thorac Oncol. 2021 Jan;16(1):21-29. (IF=15,61). Oncology (Q1); Respiratory System ((Q1).

Ravens U, Gomez AM, Heijman J, Remme CA, Dobrev D, Smith G, Volders PGA, Cerbai E, Eisner DA, Casadei B, Zaza A, Richard S, Mugelli A, Vassort G, Brown HF, Sipido KR (2021). “Edward Carmeliet (1930-2021)-channelling scientific curiosity: a tribute from the ESC Working Group on Cardiac Cellular Electrophysiology† “. Cardiovasc Res. 2021 Dec 17;117(14):e171-e173. (IF=10,79). Cardiac and Cardiovascular Systems (Q1)

Reynaud P, Ahmed E, Serre I, Knabe L, Bommart S, Suehs C, Vachier I, Berthet JP, Romagnoli M, Vernisse C, Mallet JP, Gamez AS, Bourdin A  (2021). “Club Cell Loss as a Feature of Bronchiolization in ILD.  “ . Front Immunol. 2021 Feb 26;12:630096.  (IF=7,56). Immunology (Q1).

Richalet JP, Pillard F, LE Moal D, Rivière D, Oriol P, Poussel M, Chenuel B, Doutreleau S, Vergès S, Demanez S, Vergnion M, Boulet JM, Douard H, Dupré M, Mesland O, Remetter R, Lonsdorfer-Wolf E, Frey A, Vilcoq L, Nedelec Jaffuel A, Debeaumont D, Duperrex G, Lecoq F, Hédon C, Hayot M, Giardini G, Lhuissier FJ. (2021). “Validation of a Score for the Detection of Subjects with High Risk for Severe High-Altitude Illness.  “ Med Sci Sports Exerc. 2021 Jun 1;53(6):1294-1302. (IF=5,41). Sport Sciences (Q1).

Rotty MC, Suehs CM, Mallet JP, Martinez C, Borel JC, Rabec C, Bertelli F, Bourdin A, Molinari N, Jaffuel D. (2021). “Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study.  “ Respir Res. 2021 Jan 15;22(1):17. (IF=5,63). Respiratory Systems (Q2).

Ryan D, Heatley H, Heaney LG, Jackson DJ, Pfeffer PE, Busby J, Menzies-Gow AN, Jones R, Tran TN, Al-Ahmad M, Backer V, Belhassen M, Bosnic-Anticevich S, Bourdin A, Bulathsinhala L, Carter V, Chaudhry I, Eleangovan N, FitzGerald JM, Gibson PG, Hosseini N, Kaplan A, Murray RB, Rhee CK, Van Ganse E, Price DB.. (2021). ”Potential severe asthma hidden in UK primary care.  ” J Allergy Clin Immunol Pract. 2021 Apr;9(4):1612-1623.e9. (IF=10,79). Allergy  (Q1) ;  Imunology (Q1).

Saour M, Zeroual N, Aubry E, Blin C, Gaudard P, Colson PH  (2021). “Blood loss kinetics during first 12 hours after on-pump cardiac surgery.  “ Ann Thorac Surg. 2021 Apr;111(4):1308-1315. (IF=4,33). Respiratory System (Q2) ;  Sugery  (Q1).

Sentenac P, Samarani G, Bideaux P, Sicard P, Bourdois B, Richard S, Colson PH, Eddahibi S.  (2021).Pulmonary hypertension after pneumonectomy: a preclinical model in rats and human pulmonary endothelial cells.  Eur J Cardiothorac Surg. 2021 Jan 4;59(1):147-154. (IF= 4,19). Cardiac and Cardiovascular Systems (Q2) ; Respiratory Sytems (Q2) ; Surgery » (Q1).

Souweine JS, Gouzi F, Badia É, Pomies P, Garrigue V, Morena M, Hayot M, Mercier J, Ayoub B, Quintrec ML, Raynaud F, Cristol JP  (2021). ”Skeletal Muscle Phenotype in Patients Undergoing Long-Term Hemodialysis Awaiting Kidney Transplantation. ” .Clin J Am Soc Nephrol. 2021 Nov;16(11):1676-1685.(IF=8,24). Urology and Nephrology (Q1).

Souweine JS, Pasquier G, Kuster N, Rodriguez A, Patrier L, Morena M, Badia E, Raynaud F, Chalabi L, Raynal N, Ohresser I, Hayot M, Mercier J, Quintrec ML, Gouzi F, Cristol JP. (2021). “Dynapaenia and sarcopaenia in chronic haemodialysis patients: do muscle weakness and atrophy similarly influence poor outcome?  “ Nephrol Dial Transplant. 2021 Sep 27;36(10):1908-1918. (IF=5,99). Transplantation (Q1) ; Urology and Nephrology  (Q1).

Suehs CM, Bourdin A.  (2021). “Tapering of Oral Corticosteroids for the Treatment of Asthma.  “ Arch Bronconeumol. 2021 Feb 17:sous presse. (IF=4,87). Respiratory System (Q1).

Suehs CM, Solovei L, Hireche K, Vachier I, Mariano Goulart D, Gamon L, Charriot J, Serre I, Molinari N, Bourdin ABommart S. (2021). “Complication and lung function impairment prediction using perfusion and computed tomography air trapping (CLIPPCAIR): protocol for the development and validation of a novel multivariable model for the prediction of post-resection lung function.Ann Transl Med. 2021 Jul;9(13):1092.(IF=3,93). Oncology (Q2) ; Medicine Research and Experimental (Q2).

Upham JW, Le Lievre C, Jackson DJ, Masoli M, Wechsler ME, Price DB; Delphi Panel  avec comme collaborateur Bourdin A  (2021). “Defining a Severe Asthma Super-Responder: Findings from a Delphi Process..J Allergy Clin Immunol Pract. 2021 Nov;9(11):3997-4004. (IF=10,79). Allergy  (Q1) ;  Imunology (Q1).

Vincenti M, Farah C, Amedro P, Scheuermann V, Lacampagne A, Cazorla O. (2021). “Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice.  “ Cardiovasc Drugs Ther. 2021 Jun 17. Sous presse. (IF=3,73). Cardiac and Cardiovascular Systems (Q2) : Pharmacology and Pharmacy (Q1).

Virsolvy A, Fort  A, Erceau L, Charrabi A, Hayot M , Aimond F and Richard S. (2021). “Hypoxic Conditions Promote Rhythmic Contractile Oscillations Mediated by Voltage-Gated Sodium Channels Activation in Human ArteriesInternational Journal of Molecular Sciences, 2021 Mar 4;22(5):2570. (IF=5,92).  Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary  (Q2).

Wassmer F, Suehs C, Boissin C, Bourdin A, Charriot J . (2021). “PD-L1 inhibitor-induced worsening of eosinophilic obstructive lung disease successfully rescued with anti-interleukin 5 receptor (IL-5R) therapy.  “ J Allergy Clin Immunol Pract. 2021 Jan;9(1):567-569. (IF=8,86). Allergy (Q1) ; Imunology  (Q1).

Zeroual N, Blin C, Saour M, David H, Aouinti S, Picot MC, Colson PH, Gaudard P. (2021). “Restrictive Transfusion Strategy after Cardiac Surgery. “  Anesthesiology. 2021 Mar 1;134(3):370-380..(IF=7,89). Anesthesiology (Q1).

Anselmi A, Galand V, Vincentelli A, Boule S, Dambrin C, Delmas C, Barandon L, Pernot M, Kindo M, Tam HM, Gaudard P, Rouviere P, Senage T, Michel M, Boignard A, Chavanon O, Verdonk C, Para M, Gariboldi V, Pelce E, Pozzi M, Obadia JF, Anselme F, Litzler PY, Babatasi G, Belin A, Garnier F, Bielefeld M, Guihaire J, Kloeckner M, Radu C, Lellouche N, Bourguignon T, Genet T, D’Ostrevy N, Duband B, Jouan J, Bories MC, Vanhuyse F, Blangy H, Colas F, Verhoye JP, Martins R, Flecher E. (2020). “Current results of left ventricular assist device therapy in France: the ASSIST-ICD registry.  “ Eur J Cardiothorac Surg 2020 Jul 1;58(1):112-120.. (IF=3,19). Cardiac and Cardiovascular System (Q2) ; Respiratory Sytems  (Q2) ; Surgery (Q1).

Austin CD, Gonzalez Edick M, Ferrando RE, Solon M, Baca M, Mesh K, Bradding P, Gauvreau GM, Sumino K, FitzGerald JM, Israel E, Bjermer L, Bourdin A, Arron JR, Choy DF, Olsson JK, Abreu F, Howard M, Wong K, Cai F, Peng K, Putnam WS, Holweg CTJ, Matthews JG, Kraft M, Woodruff PG; CLAVIER Investigators. (2020). “A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Clin Exp Allergy. 2020 Dec;50(12):1342-1351. (IF=5,02). Allergy (Q2); Immunology (Q2).

Bareil C, Bergougnoux A  (2020). “CFTR gene variants, epidemiology and molecular pathology.  “ Arch Pediatr. 2020 Feb;27 Suppl 1:eS8-eS12. (IF=0,59). Pediatrics ( Q4).

Bergougnoux A, Lopez M, Girodon E. (2020). “The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis.  “ Int J Neonatal Screen. 2020 Mar 21;6(1):23.. (IF=à venir).

Bieth E, Nectoux J, Girardet A, Gruchy N, Mittre H, Laurans M, Guenet D, Brouard J, Gerard M. (2020). “Genetic counseling for cystic fibrosis: A basic model with new challenges.  “ Arch Pediatr. 2020 Feb;27 Suppl 1:eS30-eS34.  (IF=0,59). Pediatrics ( Q4).

Bleecker ER, Menzies-Gow AN, Price DB, Bourdin A, Sweet S, Martin AL, Alacqua M, Tran TN.  (2020). “Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management “ .  American Journal of Respiratory and Critical Care Medicine 2020  Vol 201, Iss 3, pp 276–293, Feb 1, (IF=21,40). Critical Care Medicine  (Q1) 

Blervaque L, Pomiès P, Rossi E, Catteau M, Blandinières A, Passerieux E, Blaquière M, Ayoub B, Molinari N, Mercier J, Perez-Martin A, Marchi N, Smadja DM, Hayot M, Gouzi F. (2020). “ COPD is deleterious for pericytes: implications during training-induced angiogenesis in skeletal muscle.  “ Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H1142-H1151.  (IF=4,73). Cardiac and Cardiovascular Systems (Q2); Physiology (Q1) ; Paripheral Vascular Diseases  (Q2). 

Boulghobra D, Grillet PE, Mickaël L, Mathieu T, Fauconnier J, Fança-Berthon P, Reboul C, Cazorla O  (2020).“ Sinapine, but not sinapic acid, counteracts mitochondrial oxidative stress in cardiomyocytes. “- Redox Biology, Volume 34, July 2020, 101554 IF=11,80). Biochemistry and Molecular Biology (Q1).

Bourdin A, Gamez AS, Vachier I, Crestani B. (2020). “LAM is another small airway disease: lessons from microCT.”  Eur Respir J. 2020 Jul 2;56(1):2002162.(IF=16,67). Respiratory Systems (Q1).

Bourdin A, Romagnoli M, Gamez AS, Hireche K, Berthet JP, Mallet JP, Vachier I, Nava S, Reynaud P, Molinari N, Suehs C.  (2020). “Careful consideration of the bleeding caused by transbronchial lung cryobiopsies. “  Eur Respir J. 2020 May 21;55(5):1902415.(IF= 16,67). Respiratory Systems (Q1)

Bourdin A, Suehs CM, Colby TV, Vachier I, Molinari N, Romagnoli M; all authors of “Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases.”. (2020)  “Reply to: Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases – An Ongoing Tale.Am J Respir Crit Care Med. 2020 Jan 15;201(2):260-261 (IF=21,40). Critical Care Medicine (Q1) ; Respiratory Systems  (Q1).

Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C, de Blic J, Deschildre A, Devilliers P, Devouassoux G, Didier A, Garcia G, Magnan A, Martinat Y, Perez T, Roche N, Taillé C, Val P, Chanez P. (2020). ”How can we minimise the use of regular oral corticosteroids in asthma?Eur Respir Rev. 2020 Feb 5;29(155). (IF=8,84) Respiratory Systems  (Q1).

Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X.  (2020). “Matching-Adjusted Comparison of Oral Corticosteroid Reduction in Asthma: Systematic Review of Biologics.Clin Exp Allergy. 2020 Apr;50(4):442-452. . (IF=5,02). Immunology (Q2).

Bourdin A, Suehs C, Charriot J.(2020). “Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship. “ Eur Respir J. 2020 Jan 2;55(1) (IF=16,67). Respiratory Systems  (Q1).

Bourguignon C, Vernisse C, Mianné J, Fieldès M, Ahmed E, Petit A, Vachier I, Bertrand TL, Assou S, Bourdin A, De Vos  (2020). ”[Lung organoids].  ” MS- Med Sci (Paris). 2020 Apr;36(4):382-388.(IF=0,82). Medicine, Research and Experimental ( Q4).

Boussaroque A, Audrézet MP, Raynal C, Sermet-Gaudelus I, Bienvenu T, Férec C, Bergougnoux A, Lopez M, Scotet V, Munck A, Girodon E. (2020). “Penetrance is a critical parameter for assessing the disease liability of CFTR variants.  “ J Cyst Fibros. 2020 Nov;19(6):949-954.. (IF=5,48). Respiratory Systems (Q1).

Bughin F, Desplan M, Mestejanot C, Picot MC, Roubille F, Jaffuel D, Mercier J, Jaussent I, Dauvilliers Y.  (2020). “Effects of an individualized exercise training program on severity markers of obstructive sleep apnea syndrome: a randomised controlled trial.  “ Sleep Med. 2020 Feb 18;70:33-42.  (IF=3,49). Clinical Neurology (Q2).

Catteau M, Gouzi F, Blervaque L, Passerieux E, Blaquière M, Ayoub B, Bughin F, Mercier J, Hayot M, Pomiès P  (2020). ”Effects of a human microenvironment on the differentiation of human myoblasts.  ” Biochem Biophys Res Commun. 2020 May 14;525(4):968-973. (IF=3,57). Biochemistry and Molecular Biology (Q3); Biophysics (Q2).

Chakouri N, Farah C, Matecki S, Amedro P, Vincenti M, Saumet L, Vergely L, Sirvent N, Lacampagne A, Cazorla O. (2020). “Screening for in-vivo regional contractile defaults to predict the delayed Doxorubicin Cardiotoxicity in Juvenile Rat.  “ Theranostics. 2020 Jul 9;10(18):8130-8142. (IF=11,56). Medicine, Research and Experimental (Q1).

Charriot J, Pahus L, Chanez P, Nagot N, Bourdin A  (2020). “Letter from France. Respirology. 2020 Jul;25(7):766-768. (IF=6,42). Respiratory Systems (Q1).

Charriot J, Gaga M, Suehs C, Bourdin A.  (2020). “Asthma rescue treatments, time to reboot.  “ Eur Respir J. 2020 Apr 16;55(4):2000542 (IF=16,67). Respiratory Systems (Q1).

Charton M Flécher E, Leclercq C, Delmas C, Dambrin C, Geominne C, Vencentelli A, Michel M, Lehelias L, Verdonk C, Para M, Pozzi M, Obadia JF, Boignard A, Chavanon O, Barandon L, Nubret K, Kindo M, Minh TH, Gaudard P, Pelcé E, Gariboldi V, Litzer PY, Anselme F, Babatasi G, Belin A, Garneir F, Bielefeld M, Hamon D, Lellouche N, Bourguignon T, Genet T, Eschalier R, D’Ostrevy N, Bories MC, Jouan J, Vanhuyse F, Blangy H, Doucerain J, Martins RP, Galand V. (2020). “ Suicide Attempts Among LVAD Recipients: Real-Life Data From the ASSIST-ICD Study Circulation 2020 Mar 17;141(11):934-936.. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1)

Dupin C, Belhadi D, Guilleminault L, Gamez AS, Berger P, De Blay F, Bonniaud P, Leroyer C, Mahay G, Girodet PO, Raherison C, Fry S, Le Bourdellès G, Proust A, Rosencher L, Garcia G, Bourdin A, Chenivesse C, Didier A, Couffignal C, Taillé C. (2020). “Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort.  “ Clin Exp Allergy. 2020 Jul;50(7):789-798. (IF=5,02). Allergy (Q2); Immunology (Q2).

Erdoes G, Vuylsteke A, Schreiber JU, Alston RP, Howell SJ, Wouters PF, Guarracino F, Unic-Stojanovic D, Martinez AH, Vives M, Gaudard P, Burtin P, Bettex D, Granell M, Szekely A, van der Maaten J, Antoniou T, Jiménez MJ, Szegedi L, Seeberger M, Erb JM, Singh R, von Dossow V, Matute P, Rosseel P, Marczin N, Landoni G, Wilkinson K, Diprose P, Mukherjee C, Paternoster G, El-Tahan MR; Education and Subspecialty Committees of the European Association of Cardiothoracic Anesthesiology (EACTA). (2020). “European Association of Cardiothoracic Anesthesiology (EACTA) Cardiothoracic and Vascular Anesthesia Fellowship Curriculum: First Edition.J Cardiothorac Vasc Anesth. 2020 May;34(5):1132-1141. (IF=2,63).Anesthesiology (Q3). Cardiac and Cardiovascular Systems (Q3); Respiratory System (Q3); Peripheral Vascular Disease (Q3).

Fieldes M, Ahmed E, Bourguignon C, Mianné J, Martin M, Arnould C, Vachier I, Assou S, De Vos J, Bourdin A (2020) Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donorStem Cell Research. Volume 49, December 2020, 102037 (IF=2,02). Cell and Time Engineering  (Q2) ; Cell Biology (Q2).

Fieldès M, Ahmed E, Bourgignon C, Mianné J, Vernisse C, Fort A, Vachier I, Bourdin A, Assou S, De vos J. (2020). ”[Modelling the bronchial epithelium in chronic obstructive pulmonary disease using human induced pluripotential stem cells]  ” Rev Mal Respir 2020 Mar;37(3):197-200. (IF=0,62). Respiratory Systems (Q4).

FitzGerald JM, Tran TN, Alacqua M, Altraja A, Backer V, Bjermer L, Bjornsdottir U, Bourdin A, Brusselle G, Bulathsinhala L, Busby J, Canonica GW, Carter V, Chaudhry I, Cho YS, Christoff G, Cosio BG, Costello RW, Eleangovan N, Gibson PG, Heaney LG, Heffler E, Hew M, Hosseini N, Iwanaga T, Jackson DJ, Jones R, Koh MS, Le T, Lehtimäki L, Ludviksdottir D, Maitland-van der Zee AH, Menzies-Gow A, Murray RB, Papadopoulos NG, Perez-de-Llano L, Peters M, Pfeffer PE, Popov TA, Porsbjerg CM, Price CA, Rhee CK, Sadatsafavi M, Tohda Y, Wang E, Wechsler ME, Zangrilli J, Price DB. (2020). “International severe asthma registry (ISAR): protocol for a global registry. “  BMC Med Res Methodol. 2020 Aug 14;20(1):212. (IF=4,61). Health Care Sciences and Services (Q1)

Galand V, Flécher E, Chabanne C, Lelong B, Goéminne C, Vincentelli A, Delmas C , Dambrin C, Nubret K, Pernot M, Kindo M, Hoang Minh T, Gaudard P, Frapier JM, Michel M, Sénage T, Boignard A, Chavanon O, Verdonk C, Para M, Pelcé E, Gariboldi V, Pozzi M, Obadia JF, Litlzer PY, Anselme F, Babatasi G, Plane AF, Garnier F, Bielefeld M, Hamon D, Radu C, Bourguignon T, Genet T, Eschalier R, D’Ostrevy N, Bories MC, Marijon E, Vanhuyse F, Blangy H, Leclercq C, Martins RP (2020). “Septuagenarian population has similar survival and outcomes to younger patients after left ventricular assist device implantation.   “Archives of Cardiovascular  Dis 2020 Nov;113(11):701-709. (IF=2,34).

Galand V,  Flécher E, Chabanne C, Lelong B, Goéminne C, Vincentelli A, Delmas C, Dambrin C, Picard F, Sacher F, Kindo M, Minh TH, Gaudard P, Rouvière P, Sénage T, Michel M, Boignard A, Chavanon O, Verdonk C, Ghodhbane W, Pelcé E, Gariboldi V, Pozzi M, Obadia JF, Litzler PY, Anselme F, Babatasi G, Blanchart K, Garnier F, Bielefeld M, Hamon, Lellouche N, Bourguignon T, Genet T, Eschalier R, D’Ostrevy N, Varlet E, Jouan J, Vanhuyse F, Blangy H, Leclercq C, Martins RP (2020).Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy. Am J Cardiol 2020 May 1;125(9):1421-1428. (IF=2,78). Cardiac and Cardiovascular Systems (Q2).

Ghaleh B, Thireau J, Cazorla O, Soleti R, Scheuermann V, Bizé A, Sambin L, Roubille F, Andriantsitohaina R, Martinez M-C, Lacampagne A (2020). ” Cardioprotective effect of sonic hedgehog ligand in pig models of ischemia reperfusion.  ”  Theranostics 2020; 10(9): 4006-4016.  (IF=11,56). Medicine, Research and Experimental (Q1).

Humbert M, Bourdin A, Papadopoulos NG, Holgate ST, Hanania NA, Halpin DMG, Chapman KR, Gavornikova M, Price DB, Kaplan A, Heaney LG.(2020). “ Reducing the hidden burden of severe asthma: Recognition and referrals from primary practice.  “.J Asthma. 2020 Apr 29:1-9. (IF=2,51). Respirtory Sytem (Q3). Allergy ” (Q3).

ISAR Study Group (avec parmi les participants : Bourdin A). (2020). ”International Severe Asthma Registry: Mission Statement: The ISAR Study Group.Chest. 2020 Apr;157(4):805-814. (IF=9,41). Critical Care Medicine (Q1) ; Respiratory System  (Q1).

Jaffuel D, Rabec C, Philippe C, Mallet JP, Georges M, Redolfi S, Palot A, Suehs CM, Nogue E, Molinari N, Bourdin A.  (2020). ” Patterns of adaptive servo-ventilation settings in a real-life multicenter study: pay attention to volume! : Adaptive servo-ventilation settings in real-life conditions.  ”  Respir Res. 2020 Sep 21;21(1):243. (IF=5,63). Respiratory Systems (Q2).

Lebret M, Jaffuel D, Suehs CM, Mallet JP, Lambert L, Rotty MC, Pépin JL, Matzner-Lober E, Molinari N, Borel JC (2020). “Feasibility of Type 3 Polygraphy for Evaluating Leak Determinants in CPAP-Treated OSA Patients: A Step Toward Personalized Leak Management.  “Chest. 2020 Nov;158(5):2165-2171. (IF=9,41). Critical Care Medicine (Q1) ; Respiratory System  (Q1).

Marquette CH, Boutros J, Benzaquen J, Ferreira M, Pastre J, Pison C, Padovani B, Bettayeb F,Fallet V, Guibert, Basille D, Ilie M, Hofman V*, Hofman P*, on behalf of the AIR project Study Group (avec comme collaborateurs,  Bourdin A, Berthet JP) (2020). ” Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study Lancet Respir Med 2020 Jul;8(7):709-716.  (IF=30,70). Critical Care Medicine (Q1); Respiratory System  (Q1).

Meys R, Stoffels AAF, de Brandt J, van Hees HWH, Franssen FME, Sillen MJH, Wouters EFM, Burtin C, Klijn P, Bij de Vaate E, van den Borst B, Otker JM, Donkers J, Schleich FN, Hayot M, Pomiès P, Everaert I, Derave W, Spruit MA; BASES consortium (2020). “Beta-alanine supplementation in patients with COPD receiving non-linear periodised exercise training or neuromuscular electrical stimulation: protocol of two randomised, double-blind, placebo-controlled trials. “  BMJ Open. 2020 Sep 13;10(9):e038836. (IF=2,69). Medicine General and Internal (Q2).

Moreira Souza AC, Grabe-Guimaraes A, Cruz JDS, Santos-Miranda A, Farah C, Teixeira Oliveira L, Lucas A, Aimond F, Sicard P, Mosqueira VCF, Richard S. (2020). “ARTEMETHER TOXICITY MECHANISMS ON SINGLE CARDIOMYOCYTES AND PROTECTIVE EFFECT OF NANOENCAPSULATION. “ Br J Pharmacol. 2020 Jul 1;177(19):4448-4463 (IF=8,74). Pharmacology and Pharmacy (Q1).

Mourad M, Eliet J, Zeroual N, Saour M, Sentenac P, Manna F, Molinari N, Gandet T, Colson PH, Gaudard P.  (2020). Pulse pressure and end-tidal carbon dioxide for monitoring low native cardiac output during veno-arterial ECLS: a prospective observational study.  ” Crit Care. 2020 Sep 22;24(1):569. (IF=9,10). Critical Care Medicine (Q1).

Pagin A, Bergougnoux A, Girodon E, Reboul MP, Willoquaux C, Kesteloot M, Raynal C, Bienvenu T, Humbert M, Lalau G, Bieth E. (2020). “Novel ADGRG2 truncating variants in patients with X-linked congenital absence of vas deferens. “  Andrology. 2020 May;8(3):618-624. (IF=3,84). Andrology (Q1).

Pahus L, Suehs CM, Halimi L, Bourdin A, Chanez P, Jaffuel D, Marciano J, Gamez AS, Vachier I, Molinari N. (2020). “Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?  “ BMC Med Ethics. 2020 Aug 13;21(1):72. (IF=2,65). Medical Ethics (Q1).

Pineau F, Caimmi D, Magalhães M, Fremy E, Mohamed A, Mely L, Leroy S, Murris M, Claustres M, Chiron R, De Sario A (2020). “Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis.  “ PLoS One. 2020 Apr 17;15(4):e0231285. (IF=3,24). Multidisciplinary Sciences ( Q2).

Pommier A, Varilh J, Bleuse S, Delétang K, Bonini J, Bergougnoux A, Brochiero E, Koenig M, Claustres M, Taulan-Cadars M. (2020). “miRNA repertoires of cystic fibrosis ex vivo models highlight miR-181a and miR-101 that regulate WISP1 expression. “  J Pathol. 2020 Oct 23. . (IF=8,00). Oncology (Q1); Pathology (Q1).

Price D, Castro M, Bourdin A, Fucile S, Altman P. (2020). “Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety.  “ Eur Respir Rev. 2020 Apr 3;29(155):190151. (IF=8,84). Respiratory Systems  (Q1).

Prigent A, Gentina T, Launois S, Meurice JC, Pia d’Ortho M, Philippe C, Tamisier R, Gagnadoux F, Jaffuel D; groupe de travail de la Société française de recherche et médecine du sommeil et la Société de pneumologie de langue française. (2020). “[Telemonitoring in continuous positive airway pressure-treated patients with obstructive sleep apnoea syndrome: An algorithm proposal].  “ Rev Mal Respir. 2020 Sep;37(7):550-560. . (IF=0,62). Respiratory System (Q4).

Rabec C, Gonzalez-Bermejo J; Respiratory Support, Chronic Care Group GAVO 2 of the French Society of Respiratory Diseases SPLF;( GAVO 2 collaborators = parmi lesquels Jaffuel D). (2020). “Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases.  “Respir Med Res. 2020 May 27;78:100768. (IF =1,12).

Ranisavljevic N, Hess M, Castelli C, Willems M, Ferrieres-Hoa A, Girardet A, Anahory T. (2020). “Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?  “ J Assist Reprod Genet. 2020 Jul;37(7):1675-1683. (IF=3,41). Genetics and Heredity (Q3 ; Obstetrics and Gynecology (Q2) ; Reproductive Biology (Q2).

Raynal C, Corvol H. (2020). “Variant classifications, databases and genotype-phenotype correlations.  “ Arch Pediatr. 2020 Feb;27 Suppl 1:eS13-eS18. . (IF=0,91). Pediatrics ( Q4).

Roch B, Coffy A, Jean-Baptiste S, Palaysi E, Daures JP, Pujol JL, Bommart S.   (2020). “Cachexia – sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.  “ Lung Cancer. 2020 May;143:19-26. (IF=5,70). Oncology (Q2) ; Respiratory System (Q1).

Saour M, Zeroual N, Ridolfo J, Nogue E, Picot MC, Gaudard P, Colson PH  (2020). ”Serum Phosphate Kinetics in Acute Kidney Injury After Cardiac Surgery: An Observational Study.  ” . J Cardiothorac Vasc Anesth. 2020 Nov;34(11):2964-2972.. (IF=2,63). Anesthesiology (Q3) ; Cardiac Cardiovascular Systems (Q3) ;  Respiratory System (Q3) ; Peripheral Vascular Disease (Q3)

Sasorith S, Baux D, Bergougnoux A, Paulet D, Lahure A, Bareil C, Taulan-Cadars M, Roux AF, Koenig M, Claustres M, Raynal C. (2020). “The CYSMA web server: An example of integrative tool for in silico analysis of missense variants identified in Mendelian disorders.  “Hum Mutat. 2020 Feb;41(2):375-386. (IF=4,88). Genetics and Heredity (Q1).

Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, Horeau-Langlard D, Tromeur C, Chabanne C, Prevot G, Chaouat A, Moceri P, Artaud-Macari É, Degano B, Tresorier R, Boissin C, Bouvaist H, Simon AC, Riou M, Favrolt N, Palat S, Bourlier D, Magro P, Cottin V, Bergot E, Lamblin N, Jaïs X, Coilly A, Durand F, Francoz C, Conti F, Hervé P, Simonneau G, Montani D, Duclos-Vallée JC, Samuel D, Humbert M, De Groote P, Sitbon O. (2020). “Portopulmonary hypertension in the current era of pulmonary hypertension management.  “J Hepatol. 2020 Jul;73(1):130-139. And . J Hepatol. 2020 Nov;73(5):1293-1294. . (IF=25,08). Gastroenterology and Hepathology ( Q1).

Scott M, De Sario A (2020). “DNA methylation changes in cystic fibrosis: Cause or consequence?  “ Clin Genet. 2020 Jul;98(1):3-9. . (IF=4,44). Genetics & Heredity (Q2) Sleiman Y, Souidi M, Kumar R, Yang E, Jaffré F, Zhou T, Bernardin A, Reiken S, Cazorla O, Kajava AV, Moreau A, Pasquié JL, Marks AR, Lerman BB, Chen S, Cheung JW, Evans T, Lacampagne A, Meli AC. (2020). “Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes.  “EBioMedicine. 2020 Oct;60:103024. (IF= 8,14). Medicine Research and Experimental (Q1).

Suehs CM, Zysman M, Chenivesse C, Burgel PR, Couturaud F, Deslee G, Berger P, Raherison C, Devouassoux G, Brousse C, Roche N, Molimard M, Chinet T, Devillier P, Chanez P, Kessler R, Didier A, Martinat Y, Le Rouzic O, Bourdin A. (2020). “Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study.  “ BMJ Open. 2020 Jul 1;10(7):e035811 (IF=2,69). Medicine General and Internal (Q2).

Suehs C, Bourdin A, Vachier I, Molinari N, Romagnoli M (2020).Transbronchial cryobiopsy in the diagnosis of interstitial lung diseases: methodologies and perspectives from the Cryo-PID and COLDICE studies.  “ Ann Transl Med, 2020 Oct;8(20):1330. (IF=3,93). Oncology (Q2) ; Medicine Research and Experimental (Q2).

Taillé C, Chanez P, Devouassoux G, Didier A, Pison C, Garcia G, Charriot J, Bouée S, Gruber A, Pribil C, Bourdin A, Humbert M  (2020). ”Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.  ”  Eur Respir J. 2020 Jun 25;55(6):1902345. (IF=16,67). Respiratory Systems (Q1).

Taillé C, Chenivesse C, Devouassoux G, Bourdin A, Garcia G; G2A (Groupe Asthme et Allergie); French Language Respiratory Society SPLF Société de Pneumologie de Langue Française.(2020). ”Management of asthma during the Coronavirus disease 2019 outbreak.  ” Respir Med Res. 2020 May 25;78:100762. (IF=1,12). (Respiratory system (Q4).

Tuaillon E, Bolloré K, Pisoni A, Debiesse S, Renault C, Marie S, Groc S, Niels C, Pansu N, Dupuy AM, Morquin D, Foulongne V, Bourdin A, Le Moing V, Van de Perre P (2020) “Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients. “  J Infect. 2020 Aug;81(2):e39-e45. (IF= 6,07). Infectious Diseases (Q1)

Varga B, Meli AC, Radoslavova S, Panel M,  Lacampagne A,Gergely C,  Cazorla O, Cloitre T. (2020)“ Internal structure and remodeling in dystrophin-deficient cardiomyocytes using second harmonic generation. “.Nanomedicine, Nanotechnology, Biology and Medicine, 2020 Nov;30:102295.. (IF=6,46). Nanoscience and Nanotechnology (Q2) ; Medicine, Research and Experimental  (Q1).

Vikhorev PG, Vikhoreva NN, Yeung W, Li A, Lal S, Dos Remedios CG, Blair CA, Guglin M, Campbell KS, Yacoub MH, de Tombe P, Marston SB.(2020). “. Titin-Truncating Mutations Associated With Dilated Cardiomyopathy Alter Length-Dependent Activation And Its Modulation Via Phosphorylation.  “ Cardiovasc Res. 2020 Nov 2:cvaa316. Sous presse. (IF=10,79). Cardiac and Cardiovascular Systems (Q1)